Follow
Marcel Bekkenk
Marcel Bekkenk
Academic Medical Center and VUmc Amsterdam
Verified email at amc.uva.nl
Title
Cited by
Cited by
Year
Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of …
MW Bekkenk, FAMJ Geelen, PCV Vader, F Heule, ML Geerts, ...
Blood, The Journal of the American Society of Hematology 95 (12), 3653-3661, 2000
9372000
Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study
F Grange, MW Bekkenk, J Wechsler, C Meijer, L Cerroni, M Bernengo, ...
Journal of clinical oncology 19 (16), 3602-3610, 2001
3132001
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature
MW Bekkenk, PM Jansen, CJLM Meijer, R Willemze
Annals of oncology 15 (7), 1097-1108, 2004
2992004
Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients
MW Bekkenk, MH Vermeer, PM Jansen, AMW van Marion, ...
Blood 102 (6), 2213-2219, 2003
2762003
Clinical staging and prognostic factors in folliculotropic mycosis fungoides
S Van Santen, REJ Roach, R van Doorn, B Horváth, MS Bruijn, ...
JAMA dermatology 152 (9), 992-1000, 2016
1492016
CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas ligand, and killing inhibitory receptors and their relationship with clinical behavior
MH Vermeer, R van Doorn, D Dukers, MW Bekkenk, CJLM Meijer, ...
Journal of clinical oncology 19 (23), 4322-4329, 2001
1412001
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer
C Assaf, S Gellrich, S Whittaker, A Robson, L Cerroni, C Massone, H Kerl, ...
Journal of clinical pathology 60 (9), 981-989, 2007
1312007
Development and validation of the Vitiligo Extent Score (VES): an international collaborative initiative
N van Geel, J Lommerts, M Bekkenk, A Wolkerstorfer, CAC Prinsen, ...
Journal of Investigative Dermatology 136 (5), 978-984, 2016
1212016
Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients
MW Bekkenk, MH Vermeer, M Noordijk, F Heule, PC van Voorst Vader, ...
Journal of clinical oncology 17 (8), 2471-2478, 1999
1121999
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
L Wieske, KPJ van Dam, M Steenhuis, EW Stalman, LYL Kummer, ...
The Lancet Rheumatology 4 (5), e338-e350, 2022
992022
Primary and secondary cutaneous CD30-positive lymphoproliferative disorders: long term follow-up data of 219 patients and guidelines for diagnosis and treatment. A report from …
M Bekkenk, F Geelen, PC van Voorst Vader, F Heule, ML Geerts, ...
Blood 95 (12), 3653-3661, 2000
622000
Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group
S Van Santen, R van Doorn, KJ Neelis, LA Daniëls, B Horváth, MS Bruijn, ...
British Journal of Dermatology 177 (1), 223-228, 2017
542017
Diagnostic accuracy of confocal microscopy imaging vs. punch biopsy for diagnosing and subtyping basal cell carcinoma
DJ Kadouch, MM Leeflang, YS Elshot, C Longo, M Ulrich, AC van der Wal, ...
Journal of the European Academy of Dermatology and Venereology 31 (10), 1641 …, 2017
502017
Breakthrough SARS-CoV-2 infections with the delta (B. 1.617. 2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy …
L Boekel, EW Stalman, L Wieske, F Hooijberg, KPJ van Dam, YR Besten, ...
The Lancet Rheumatology 4 (6), e417-e429, 2022
482022
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148
J Fang, J Jia, M Makowski, M Xu, Z Wang, T Zhang, JW Hoskins, J Choi, ...
Nature communications 8 (1), 15034, 2017
482017
Finding consensus after two decades of breast implant-associated anaplastic large cell lymphoma
MW Clemens, RC DeCoster, B Fairchild, AA Bessonov, FS Di Pompeo
Seminars in Plastic Surgery 33 (04), 270-278, 2019
472019
Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference
EY Gan, V Eleftheriadou, S Esmat, I Hamzavi, T Passeron, M Böhm, ...
Pigment cell & melanoma research 30 (1), 28-40, 2017
472017
EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate
MW Bekkenk, MH Vermeer, CJLM Meijer, PM Jansen, JM Middeldorp, ...
Blood 102 (12), 4243-4243, 2003
462003
Development and validation of a patient-reported outcome measure in vitiligo: the Self Assessment Vitiligo Extent Score (SA-VES)
N van Geel, JE Lommerts, MW Bekkenk, CAC Prinsen, V Eleftheriadou, ...
Journal of the American Academy of Dermatology 76 (3), 464-471, 2017
422017
Lymphomatoid papulosis with a natural killer‐cell phenotype
MW Bekkenk, PM Kluin, PM Jansen, CJLM Meijer, R Willemze
British journal of dermatology 145 (2), 318-322, 2001
402001
The system can't perform the operation now. Try again later.
Articles 1–20